Results 241 to 250 of about 26,037 (262)

Cytotoxic therapy for severe avian influenza A (H5N1) infection

Lancet, The, 2006
Jan-Inge Henter
exaly  

Prepandemic influenza vaccine H5N1 (split virion, inactivated, adjuvanted; Prepandrix™): a guide to its use as an active immunization against influenza A subtype H5N1 virus

Drugs & Therapy Perspectives, 2009
openaire   +1 more source

Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?

Lancet, The, 2002
Peiris, Jsm
exaly  

Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial

Lancet, The, 2006
Odile Launay
exaly  

Influenza A virus subtype H5N1 infection in humans.

Communicable disease report. CDR weekly, 1998
openaire   +1 more source

Safety and Immunogenicity of an Inactivated Subvirion Influenza A (H5N1) Vaccine

New England Journal of Medicine, 2006
Thomas Rowe
exaly  

Glycan microarray technologies: tools to survey host specificity of influenza viruses

Nature Reviews Microbiology, 2006
James Stevens, Ola Blixt, James C Paulson   +2 more
exaly  

Avian Influenza Virus (H5N1): a Threat to Human Health

Clinical Microbiology Reviews, 2007
Peiris, Jsm, Yi Guan
exaly  

Influenza A virus subtype H5N1 infection in humans: update.

Communicable disease report. CDR weekly, 1998
openaire   +1 more source

Advances in the development of influenza virus vaccines

Nature Reviews Drug Discovery, 2015
Florian H Krammer, Peter Palese
exaly